Gold
A heritage 140 years strong: company founded on May 10, 1876. Headquarters located in Indianapolis, Indiana, U.S.A. Approximately 41,000 employees worldwide. More than 9,000 employees engaged in research and development. Clinical research conducted in more than 55 countries. Research and development facilities located in six countries. Manufacturing plants located in 13 countries. Products marketed in 120 countries.
Lundbeck is a global pharmaceutical company highly committed to improving the quality of life of people living with psychiatric and neurological disorders. For this purpose, Lundbeck is engaged in the research, development, production, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at disease areas such as depression, schizophrenia, Parkinson’s disease and Alzheimer’s disease.
NewBridge pharmaceuticals is a regional specialty company providing a one-stop-solution to pharmaceuticals, biological, genomics and other innovative healthcare companies. Our focus is on in-licensing and commercializing FDA and EMA/European approved innovative therapeutics and diagnostics that address unmet medical needs of diseases with high prevalence within the emerging markets of the AfMET region (Africa, Middle East & Turkey).